{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T16:02:27Z","timestamp":1777046547584,"version":"3.51.4"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Portuguese Foundation for Science and Technology","award":["UIDB\/00772\/2020"],"award-info":[{"award-number":["UIDB\/00772\/2020"]}]},{"name":"Portuguese Foundation for Science and Technology","award":["UIDB\/04033\/ 2020"],"award-info":[{"award-number":["UIDB\/04033\/ 2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC) remains a major health challenge due to its late-stage diagnosis and the variability in patient prognosis. This study explores the potential of DNA damage in peripheral blood lymphocytes (PBLs) as a biomarker for CRC, comparing it with standard clinical parameters. We assessed DNA strand breaks using the alkaline comet assay in 27 CRC patients at diagnosis and posttreatment, comparing these levels with 31 healthy controls. Patients received 5-fluorouracil (5-FU)-based chemotherapy (with irinotecan or oxaliplatin), radiotherapy, or combined chemoradiotherapy. At diagnosis (t0), DNA damage in PBLs was significantly higher in CRC compared to healthy controls (mean\u2009\u00b1\u2009SD %DNA in tail: CRC 27.9\u2009\u00b1\u200914.0%; controls 6.5\u2009\u00b1\u20093.8%; P\u2009=\u2009.001), and independently of common confounding factors (sex, age, smoking, and alcohol consumption). Crucially, the prognostic signal came from baseline (t0): 6 of 27 patients relapsed\/metastasized within 8\u201310\u00a0months, and high-DNA-damage basal levels were the only significant prognostic predictor (P\u2009=\u2009.0137), yielding an infinitely elevated odds ratio (95% CI: \u22652.203) and 100% sensitivity. In stark contrast, carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) showed limited performance. At t0, among patients with available serum data (n\u2009=\u200923), most values were below clinical cut-offs: CEA 3\u00a0ng\/ml (14\/23, 61%); CA19-9 37\u00a0U\/ml (19\/23, 83%). Prognostic sensitivities were 50.0% (CEA) and 16.7% (CA19-9). Posttreatment (t1) increases in DNA damage are pharmacodynamically expected with DNA-damaging therapy. t1 values were higher in patients who relapsed (P\u2009&amp;lt;\u2009.001), whereas the within-patient change (\u0394\u2009=\u2009t1\u2009\u2212\u2009t0) was not associated with outcome (P\u2009=\u2009.148); these posttreatment findings are exploratory. Evaluating DNA damage in PBLs, therefore, offers a valuable noninvasive biomarker for early detection, treatment monitoring, and short-term risk stratification in CRC, warranting validation in larger, stage-balanced cohorts.<\/jats:p>","DOI":"10.1093\/mutage\/geag001","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:28:04Z","timestamp":1767702484000},"page":"91-100","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating DNA damage in peripheral blood lymphocytes: a promising biomarker for diagnosis, prognosis, and treatment monitoring in colorectal cancer"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-4615","authenticated-orcid":false,"given":"Ana Rita","family":"Guedes","sequence":"first","affiliation":[{"name":"Animal and Veterinary Research Center (CECAV), Department of Genetics and Biotechnology, University of Tr\u00e1s-os-Montes and Alto Douro (UTAD), Quinta de Prados , 5000-801 Vila Real ,","place":["Portugal"]},{"name":"Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), UTAD, Quinta de Prados , 5000-801 Vila Real ,","place":["Portugal"]},{"name":"Department of Biology and Environment (DeBA) and Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB), UTAD, Quinta de Prados , 5000-801 Vila Real ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Cunha","sequence":"additional","affiliation":[{"name":"Department of Oncology, Centro Hospitalar de Tr\u00e1s-os-Montes e Alto Douro EPE, Avenida da Noruega , 5000-508 Vila Real ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lia M","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Biology and Environment (DeBA) and Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB), UTAD, Quinta de Prados , 5000-801 Vila Real ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Gaiv\u00e3o","sequence":"additional","affiliation":[{"name":"Animal and Veterinary Research Center (CECAV), Department of Genetics and Biotechnology, University of Tr\u00e1s-os-Montes and Alto Douro (UTAD), Quinta de Prados , 5000-801 Vila Real ,","place":["Portugal"]},{"name":"Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), UTAD, Quinta de Prados , 5000-801 Vila Real ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026042410512355500_ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026042410512355500_ref2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40880-015-0066-y","article-title":"Molecular pathogenesis of sporadic colorectal cancers","volume":"35","author":"Yamagishi","year":"2016","journal-title":"Chin J Cancer"},{"key":"2026042410512355500_ref3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.24343","article-title":"The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence","volume":"125","author":"Huxley","year":"2009","journal-title":"Int J Cancer"},{"key":"2026042410512355500_ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020456","article-title":"Red and processed meat and colorectal cancer incidence: Meta-analysis of prospective studies","volume":"6","author":"Chan","year":"2011","journal-title":"PLoS One"},{"key":"2026042410512355500_ref5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cgh.2009.01.008","article-title":"Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis","volume":"7","author":"Nguyen","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026042410512355500_ref6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"2026042410512355500_ref7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcol.2016.06.005","article-title":"Crohn\u2019s disease: risk factor for colorectal cancer","volume":"37","author":"Santos","year":"2017","journal-title":"J Coloproctol"},{"key":"2026042410512355500_ref8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejca.2017.09.022","article-title":"Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability\/DNA mismatch repair deficiency","volume":"86","author":"Cohen","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026042410512355500_ref9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/CIA.S109285","article-title":"Colorectal cancer development and advances in screening","volume":"11","author":"Simon","year":"2016","journal-title":"Clin Interv Aging"},{"key":"2026042410512355500_ref10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000446488","article-title":"Diagnostics and epidemiology of colorectal cancer","volume":"32","author":"Kolligs","year":"2016","journal-title":"Visc Med"},{"key":"2026042410512355500_ref11","doi-asserted-by":"publisher","first-page":"e37622","DOI":"10.7759\/cureus.37622","article-title":"Colorectal cancer diagnostic methods: the present and future","volume":"15","author":"Gude","year":"2023","journal-title":"Cureus"},{"key":"2026042410512355500_ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081889","article-title":"Colorectal cancer diagnosis: the obstacles we face in determining a non-invasive test and current advances in biomarker detection","volume":"14","author":"Kamel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026042410512355500_ref13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s12094-024-03429-0","article-title":"Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer","volume":"26","author":"Ren","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"2026042410512355500_ref14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2026042410512355500_ref15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.dnarep.2018.07.005","article-title":"DNA damage response and repair in colorectal cancer: defects, regulation and therapeutic implications","volume":"69","author":"Mirza-Aghazadeh-Attari","year":"2018","journal-title":"DNA Repair (Amst)"},{"key":"2026042410512355500_ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12082098","article-title":"DNA damage-inducing anticancer therapies: from global to precision damage","volume":"12","author":"Reuvers","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026042410512355500_ref17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pili\u00e9","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"2026042410512355500_ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020752","article-title":"Biology and development of DNA-targeted drugs, focusing on synthetic lethality, DNA repair, and epigenetic modifications for cancer: a review","volume":"25","author":"Watanabe","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026042410512355500_ref19","first-page":"42","article-title":"Adjuvant treatment of colorectal cancer","volume":"2","author":"Carrato","year":"2008","journal-title":"Gastrointest Cancer Res"},{"key":"2026042410512355500_ref20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1272\/jnms.JNMS.2022_89-310","article-title":"Recent advances in the treatment of colorectal cancer: a review","volume":"89","author":"Shinji","year":"2022","journal-title":"Journal Nippon Med School"},{"key":"2026042410512355500_ref21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2298\/AOO0304255S","article-title":"Systemic therapy for colorectal cancer","volume":"11","author":"Meyerhardt","year":"2005","journal-title":"Arch Oncol"},{"key":"2026042410512355500_ref22","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol Ther"},{"key":"2026042410512355500_ref23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cellbi.2009.01.007","article-title":"Comparative study of DNA damage and repair in head and neck cancer after radiation treatment","volume":"33","author":"Rusin","year":"2009","journal-title":"Cell Biol Int"},{"key":"2026042410512355500_ref24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.52547\/ijrr.20.2.15","article-title":"Evaluation of the types and frequency of unstable chromosomal aberrations induced in lymphocytes of breast cancer patients before and after radiotherapy","volume":"20","author":"Mozdarani","year":"2022","journal-title":"Int J Radiat Res"},{"key":"2026042410512355500_ref25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/mutage\/ger088","article-title":"Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls","volume":"27","author":"Slyskova","year":"2012","journal-title":"Mutagenesis"},{"key":"2026042410512355500_ref26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.dnarep.2018.01.005","article-title":"DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients\u2014a pilot study","volume":"63","author":"Kv\u00e6rner","year":"2018","journal-title":"DNA Repair (Amst)"},{"key":"2026042410512355500_ref27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21294\/1814-4861-2022-21-3-33-41","article-title":"DNA damage in peripheral blood mononuclear cells in patients with melanoma","volume":"21","author":"Tsyrlina","year":"2022","journal-title":"Siberian J Oncol"},{"key":"2026042410512355500_ref28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mrfmmm.2004.04.001","article-title":"Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer","volume":"554","author":"Blasiak","year":"2004","journal-title":"Mutat Res"},{"key":"2026042410512355500_ref29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tox.2006.04.040","article-title":"Variation of ATM protein expression in response to irradiation of lymphocytes in lung cancer patients and controls","volume":"224","author":"Jianlin","year":"2006","journal-title":"Toxicology"},{"key":"2026042410512355500_ref30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3816\/CCC.2008.n.034","article-title":"Analysis of oxidative DNA damage in patients with colorectal cancer","volume":"7","author":"Ribeiro","year":"2008","journal-title":"Clin Colorectal Cancer"},{"key":"2026042410512355500_ref31","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/cam4.477","article-title":"Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo","volume":"4","author":"Wood","year":"2015","journal-title":"Cancer Med"},{"key":"2026042410512355500_ref32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up \u2606","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann Oncol"},{"key":"2026042410512355500_ref33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"key":"2026042410512355500_ref34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up \u2606","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"2026042410512355500_ref35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.toxlet.2019.11.010","article-title":"Application of the comet assay for the evaluation of DNA damage from frozen human whole blood samples: implications for human biomonitoring","volume":"319","author":"Gajski","year":"2020","journal-title":"Toxicol Lett"},{"key":"2026042410512355500_ref36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41596-022-00754-y","article-title":"Measuring DNA modifications with the comet assay: a compendium of protocols","volume":"18","author":"Collins","year":"2023","journal-title":"Nat Protoc"},{"key":"2026042410512355500_ref37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/mutage\/gem051","article-title":"The comet assay: topical issues","volume":"23","author":"Collins","year":"2008","journal-title":"Mutagenesis"},{"key":"2026042410512355500_ref38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/mutage\/geq105","article-title":"The influence of scoring method on variability in results obtained with the comet assay","volume":"26","author":"Azqueta","year":"2011","journal-title":"Mutagenesis"},{"key":"2026042410512355500_ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23020852","article-title":"Novel diagnostic biomarkers in colorectal cancer","volume":"23","author":"Zygulska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026042410512355500_ref40","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1093\/carcin\/bgv031","article-title":"Causes of genome instability: the effect of low dose chemical exposures in modern society","volume":"36","author":"Langie","year":"2015","journal-title":"Carcinogenesis"},{"key":"2026042410512355500_ref41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/mutage\/geh025","article-title":"Endogenous DNA damage in humans: a review of quantitative data","volume":"19","author":"De Bont","year":"2004","journal-title":"Mutagenesis"},{"key":"2026042410512355500_ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-081313-121208","article-title":"The DNA damage response: implications for tumor responses to radiation and chemotherapy","volume":"66","author":"Goldstein","year":"2015","journal-title":"Annu Rev Med"},{"key":"2026042410512355500_ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/18758592241308748","article-title":"DNA damage of peripheral blood lymphocytes as a dual biomarker: diagnostic and treatment response in woman breast cancer patients","volume":"42","author":"Guedes","year":"2025","journal-title":"Cancer Biomark"},{"key":"2026042410512355500_ref44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.20452\/pamw.2337","article-title":"DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer","volume":"124","author":"Szymczak","year":"2014","journal-title":"Pol Arch Med Wewn"},{"key":"2026042410512355500_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"Inflammation-induced DNA damage, mutations and cancer","volume":"83","author":"Kay","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"2026042410512355500_ref46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.mrfmmm.2005.05.005","article-title":"Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome","volume":"578","author":"Demirbag","year":"2005","journal-title":"Mutat Res"},{"key":"2026042410512355500_ref47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0040-1717126","article-title":"Association between DNA damage and serum levels of copper, zinc, and selenium in full-term neonates with late-onset sepsis","volume":"15","author":"Wahby","year":"2020","journal-title":"J Pediatr Infect Dis"},{"key":"2026042410512355500_ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158002","article-title":"Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026042410512355500_ref49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.7754\/Clin.Lab.2017.170914","article-title":"Serum CEA and CA19-9 levels are associated with the presence and severity of colorectal neoplasia","volume":"64","author":"Zhai","year":"2018","journal-title":"Clin Lab"},{"key":"2026042410512355500_ref50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5455\/medarh.2013.67.397-401","article-title":"Cancer antigens (CEA and CA 19-9) as markers of advanced stage of colorectal carcinoma","volume":"67","author":"Vukobrat-Bijedic","year":"2013","journal-title":"Med Arch"},{"key":"2026042410512355500_ref51","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.4240\/wjgs.v15.i12.2907","article-title":"Significance of carcinoembryonic antigen detection in the early diagnosis of colorectal cancer: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2023","journal-title":"World J Gastrointest Surg"},{"key":"2026042410512355500_ref52","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9010021","article-title":"Diagnostic and prognostic value of CEA and CA19-9 in colorectal cancer","volume":"9","author":"Lakemeyer","year":"2021","journal-title":"Diseases"},{"key":"2026042410512355500_ref53","doi-asserted-by":"publisher","first-page":"241.e15","DOI":"10.1016\/j.urolonc.2018.01.006","article-title":"The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer","volume":"36","author":"Allione","year":"2018","journal-title":"Urol Oncol"},{"key":"2026042410512355500_ref54","first-page":"6985","article-title":"High expression of phospho-H2AX predicts a poor prognosis in colorectal cancer","volume":"35","author":"Lee","year":"2015","journal-title":"Anticancer Res"},{"key":"2026042410512355500_ref55","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.7150\/thno.24699","article-title":"DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells","volume":"8","author":"Laengle","year":"2018","journal-title":"Theranostics"},{"key":"2026042410512355500_ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10561-w","article-title":"Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer","volume":"12","author":"Song","year":"2022","journal-title":"Sci Rep"},{"key":"2026042410512355500_ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.872238","article-title":"DNA repair-related gene signature in predicting prognosis of colorectal cancer patients","volume":"13","author":"Lv","year":"2022","journal-title":"Front Genet"},{"key":"2026042410512355500_ref58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683605","article-title":"Novel prognostic biomarkers in metastatic and locally advanced colorectal cancer: micronuclei frequency and telomerase activity in peripheral blood lymphocytes","volume":"11","author":"Nikolouzakis","year":"2021","journal-title":"Front Oncol"},{"key":"2026042410512355500_ref59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/tcm.1035","article-title":"Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay","volume":"22","author":"Kopjar","year":"2002","journal-title":"Teratog Carcinog Mutagen"},{"key":"2026042410512355500_ref60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mrgentox.2013.01.003","article-title":"Evaluation of the in vivo genotoxic effects of gamma radiation on the peripheral blood leukocytes of head and neck cancer patients undergoing radiotherapy","volume":"752","author":"Kadam","year":"2013","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"2026042410512355500_ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjw044","article-title":"Fecal lactoferrin, calprotectin, PMN-elastase, CRP and white blood cell count as an indicator for mucosal healing and clinical course of disease in patients with mild to moderate ulcerative colitis: post hoc analysis of a prospective clinical trial","volume":"10","author":"Langhorst","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2026042410512355500_ref62","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/ijc.28384","article-title":"Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update","volume":"134","author":"Duffy","year":"2014","journal-title":"Int J Cancer"},{"key":"2026042410512355500_ref63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: biochemical and clinical aspects","volume":"867","author":"Scar\u00e0","year":"2015","journal-title":"Adv Exp Med Biol"}],"container-title":["Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mutage\/advance-article-pdf\/doi\/10.1093\/mutage\/geag001\/66323147\/geag001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mutage\/article-pdf\/41\/3\/91\/66323147\/geag001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mutage\/article-pdf\/41\/3\/91\/66323147\/geag001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:51:41Z","timestamp":1777042301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mutage\/article\/41\/3\/91\/8418055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026,4,24]]}},"URL":"https:\/\/doi.org\/10.1093\/mutage\/geag001","relation":{},"ISSN":["0267-8357","1464-3804"],"issn-type":[{"value":"0267-8357","type":"print"},{"value":"1464-3804","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,1,9]]}}}